{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T06:28:16Z","timestamp":1777616896777,"version":"3.51.4"},"reference-count":33,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000025","name":"National Institute of Mental Health","doi-asserted-by":"publisher","award":["1R34MH119007-01"],"award-info":[{"award-number":["1R34MH119007-01"]}],"id":[{"id":"10.13039\/100000025","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","japha.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American Pharmacists Association"],"published-print":{"date-parts":[[2021,1]]},"DOI":"10.1016\/j.japh.2020.10.005","type":"journal-article","created":{"date-parts":[[2020,11,16]],"date-time":"2020-11-16T18:34:27Z","timestamp":1605551667000},"page":"115-120","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":28,"title":["Support and perceived barriers to implementing pre-exposure prophylaxis screening and dispensing in pharmacies: Examining concordance between pharmacy technicians and pharmacists"],"prefix":"10.1016","volume":"61","author":[{"given":"Roderick","family":"Hopkins","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9525-7401","authenticated-orcid":false,"given":"Dorie","family":"Josma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3896-0501","authenticated-orcid":false,"given":"Joseph","family":"Morris","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Donald G.","family":"Klepser","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Henry N.","family":"Young","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4859-6304","authenticated-orcid":false,"given":"Natalie D.","family":"Crawford","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.japh.2020.10.005_bib2","doi-asserted-by":"crossref","first-page":"615","DOI":"10.2147\/VHRM.S56056","article-title":"Improving medication adherence in hypercholesterolemia: challenges and solutions","volume":"10","author":"Gatwood","year":"2014","journal-title":"Vasc Health Risk Manag"},{"issue":"4","key":"10.1016\/j.japh.2020.10.005_bib3","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1002\/phar.1727","article-title":"Evaluation of pharmacists\u2019 work in a physician-pharmacist collaborative model for the management of hypertension","volume":"36","author":"Isetts","year":"2016","journal-title":"Pharmacotherapy"},{"issue":"10","key":"10.1016\/j.japh.2020.10.005_bib4","first-page":"632","article-title":"Provision of medication therapy management by pharmacists to patients with type-2 diabetes mellitus in a federally qualified health center","volume":"42","author":"Ndefo","year":"2017","journal-title":"P\u00a0T"},{"issue":"3","key":"10.1016\/j.japh.2020.10.005_bib5","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1089\/lgbt.2014.0010","article-title":"Preferences of gay and bisexual men for pharmacy-based HIV testing and over-the-counter HIV tests","volume":"1","author":"Meyerson","year":"2014","journal-title":"LGBT Health"},{"issue":"1","key":"10.1016\/j.japh.2020.10.005_bib7","first-page":"176","article-title":"Individual- and neighborhood-level characteristics associated with support of in-pharmacy vaccination among ESAP-registered pharmacies: pharmacists\u2019 role in reducing racial\/ethnic disparities in influenza vaccinations in New York City","volume":"88","author":"Crawford","year":"2011","journal-title":"J\u00a0Urban Health"},{"issue":"Suppl 1","key":"10.1016\/j.japh.2020.10.005_bib8","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1177\/00333549161310S116","article-title":"Pharmacy intervention to improve HIV testing uptake using a comprehensive health screening approach","volume":"131 Suppl 1","author":"Crawford","year":"2016","journal-title":"Public Health Rep"},{"issue":"26","key":"10.1016\/j.japh.2020.10.005_bib9","doi-asserted-by":"crossref","first-page":"2489","DOI":"10.1056\/NEJMp1912293","article-title":"PrEParing to end the HIV epidemic - California\u2019s route as a road map for the United States","volume":"381","author":"Kazi","year":"2019","journal-title":"N\u00a0Engl J Med"},{"issue":"8","key":"10.1016\/j.japh.2020.10.005_bib10","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1097\/OLQ.0000000000001017","article-title":"Iowa telePrEP: a public-health-partnered telehealth model for human immunodeficiency virus preexposure prophylaxis delivery in a rural state","volume":"46","author":"Hoth","year":"2019","journal-title":"Sex Transm Dis"},{"issue":"6","key":"10.1016\/j.japh.2020.10.005_bib11","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1071\/SH18084","article-title":"Implementation of a community pharmacy-based pre-exposure prophylaxis service: a novel model for pre-exposure prophylaxis care","volume":"15","author":"Tung","year":"2018","journal-title":"Sex Health"},{"issue":"1","key":"10.1016\/j.japh.2020.10.005_bib12","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.japh.2019.06.021","article-title":"Implementation of pre-exposure prophylaxis at a community pharmacy through a collaborative practice agreement with San Francisco Department of Public Health","volume":"60","author":"Lopez","year":"2020","journal-title":"J\u00a0Am Pharm Assoc (2003)"},{"key":"10.1016\/j.japh.2020.10.005_bib13","doi-asserted-by":"crossref","unstructured":"Crawford ND, Albarran T, Chamberlain A, et al. Willingness to discuss and screen for pre-exposure prophylaxis in pharmacies among men who have sex with men [e-pub ahead of print]. J Pharm Pract. https:\/\/doi.org\/10.1177\/0897190020904590. Accessed October 28, 2020.","DOI":"10.1177\/0897190020904590"},{"issue":"5","key":"10.1016\/j.japh.2020.10.005_bib14","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1089\/apc.2018.0294","article-title":"The pharmacist\u2019s expanding role in HIV pre-exposure prophylaxis","volume":"33","author":"Farmer","year":"2019","journal-title":"AIDS Patient Care STDs"},{"issue":"10","key":"10.1016\/j.japh.2020.10.005_bib15","doi-asserted-by":"crossref","first-page":"ofz365","DOI":"10.1093\/ofid\/ofz365","article-title":"Acceptability and feasibility of a pharmacist-led HIV pre-exposure prophylaxis (PrEP) program in the Midwestern United States","volume":"6","author":"Havens","year":"2019","journal-title":"Open Forum Infect Dis"},{"issue":"5","key":"10.1016\/j.japh.2020.10.005_bib16","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/j.japh.2016.05.004","article-title":"Understanding community pharmacist perceptions and knowledge about HIV preexposure prophylaxis (PrEP) therapy in a Mountain West state","volume":"56","author":"Unni","year":"2016","journal-title":"J\u00a0Am Pharm Assoc (2003)"},{"issue":"1","key":"10.1016\/j.japh.2020.10.005_bib17","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1089\/apc.2019.0235","article-title":"A\u00a0pharmacist-led, same-day, HIV pre-exposure prophylaxis initiation program to increase PrEP uptake and decrease time to PrEP initiation","volume":"34","author":"Khosropour","year":"2020","journal-title":"AIDS Patient Care STDs"},{"issue":"4","key":"10.1016\/j.japh.2020.10.005_bib18","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1002\/phar.2240","article-title":"Review of real-world implementation data on emtricitabine-tenofovir disoproxil fumarate as HIV pre-exposure prophylaxis in the United States","volume":"39","author":"Adams","year":"2019","journal-title":"Pharmacotherapy"},{"issue":"4","key":"10.1016\/j.japh.2020.10.005_bib19","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/j.japh.2018.04.007","article-title":"HIV pre-exposure prophylaxis: exploring the potential for expanding the role of pharmacists in public health","volume":"58","author":"Okoro","year":"2018","journal-title":"J\u00a0Am Pharm Assoc (2003)"},{"issue":"3","key":"10.1016\/j.japh.2020.10.005_bib20","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1089\/apc.2019.0189","article-title":"Health care provider barriers to HIV pre-exposure prophylaxis in the United States: a systematic review","volume":"34","author":"Pleuhs","year":"2020","journal-title":"AIDS Patient Care STDS"},{"issue":"4","key":"10.1016\/j.japh.2020.10.005_bib21","doi-asserted-by":"crossref","first-page":"113","DOI":"10.3390\/pharmacy6040113","article-title":"Pharmacy technicians\u2019 willingness to perform emerging tasks in community practice","volume":"6","author":"Doucette","year":"2018","journal-title":"Pharmacy (Basel)"},{"issue":"2","key":"10.1016\/j.japh.2020.10.005_bib22","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.japh.2017.12.011","article-title":"Pharmacy technician involvement in community pharmacy medication therapy management","volume":"58","author":"Lengel","year":"2018","journal-title":"J\u00a0Am Pharm Assoc (2003)"},{"issue":"19","key":"10.1016\/j.japh.2020.10.005_bib23","doi-asserted-by":"crossref","first-page":"1824","DOI":"10.2146\/ajhp110022","article-title":"Tech-check-tech\": a review of the evidence on its safety and benefits","volume":"68","author":"Adams","year":"2011","journal-title":"Am J Health Syst Pharm"},{"issue":"2","key":"10.1016\/j.japh.2020.10.005_bib24","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.japh.2018.01.003","article-title":"Training pharmacy technicians to administer immunizations","volume":"58","author":"McKeirnan","year":"2018","journal-title":"J\u00a0Am Pharm Assoc (2003)"},{"key":"10.1016\/j.japh.2020.10.005_bib25","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1186\/1748-5908-4-50","article-title":"Fostering implementation of health services research findings into practice: a consolidated framework for advancing implementation science","volume":"4","author":"Damschroder","year":"2009","journal-title":"Implement Sci"},{"issue":"1","key":"10.1016\/j.japh.2020.10.005_bib26","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/s13012-017-0550-7","article-title":"Using the Consolidated Framework for Implementation Research (CFIR) to produce actionable findings: a rapid-cycle evaluation approach to improving implementation","volume":"12","author":"Keith","year":"2017","journal-title":"Implement Sci"},{"key":"10.1016\/j.japh.2020.10.005_bib27","first-page":"1","article-title":"Using the Consolidated Framework for Implementation Research (CFIR) to evaluate implementation effectiveness of a facilitated approach to an asthma shared decision making intervention [e-pub ahead of print]","author":"Shade","year":"2019","journal-title":"J\u00a0Asthma"},{"issue":"6","key":"10.1016\/j.japh.2020.10.005_bib29","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1093\/intqhc\/mzm042","article-title":"Consolidated criteria for reporting qualitative research (COREQ): a 32-item checklist for interviews and focus groups","volume":"19","author":"Tong","year":"2007","journal-title":"Int J Qual Health Care"},{"key":"10.1016\/j.japh.2020.10.005_bib30","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1186\/1471-2288-13-117","article-title":"Using the framework method for the analysis of qualitative data in multi-disciplinary health research","volume":"13","author":"Gale","year":"2013","journal-title":"BMC Med Res Methodol"},{"issue":"4","key":"10.1016\/j.japh.2020.10.005_bib32","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1016\/j.japh.2019.12.003","article-title":"Pharmacy-based pre-exposure prophylaxis support among pharmacists and men who have sex with men","volume":"60","author":"Crawford","year":"2020","journal-title":"J\u00a0Am Pharm Assoc (2003)"},{"issue":"6","key":"10.1016\/j.japh.2020.10.005_bib33","doi-asserted-by":"crossref","first-page":"2109","DOI":"10.1007\/s10461-013-0427-y","article-title":"We can do more than just sell the test: pharmacist perspectives about over-the-counter rapid HIV tests","volume":"17","author":"Meyerson","year":"2013","journal-title":"AIDS Behav"},{"issue":"11","key":"10.1016\/j.japh.2020.10.005_bib34","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0207372","article-title":"Midwest pharmacists\u2019 familiarity, experience, and willingness to provide pre-exposure prophylaxis (PrEP) for HIV","volume":"13","author":"Broekhuis","year":"2018","journal-title":"PLoS One"},{"issue":"5","key":"10.1016\/j.japh.2020.10.005_bib35","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1331\/JAPhA.2014.14045","article-title":"HIV testing in community pharmacies and retail clinics: a model to expand access to screening for HIV infection","volume":"54","author":"Weidle","year":"2014","journal-title":"J\u00a0Am Pharm Assoc (2003)"},{"issue":"2_suppl","key":"10.1016\/j.japh.2020.10.005_bib36","doi-asserted-by":"crossref","first-page":"34S","DOI":"10.1177\/0033354918801026","article-title":"The \"no wrong door\" approach to HIV testing: results from a statewide retail pharmacy-based HIV testing program in Virginia, 2014\u20132016","volume":"133","author":"Collins","year":"2018","journal-title":"Public Health Rep"},{"issue":"4","key":"10.1016\/j.japh.2020.10.005_bib37","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1016\/j.japh.2019.12.003","article-title":"Pharmacy-based pre-exposure prophylaxis support among pharmacists and men who have sex with men.","volume":"60","author":"Crawford","year":"2020","journal-title":"J Am Pharm Assoc"}],"container-title":["Journal of the American Pharmacists Association"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1544319120304891?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1544319120304891?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T05:48:11Z","timestamp":1761544091000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1544319120304891"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1]]},"references-count":33,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,1]]}},"alternative-id":["S1544319120304891"],"URL":"https:\/\/doi.org\/10.1016\/j.japh.2020.10.005","relation":{},"ISSN":["1544-3191"],"issn-type":[{"value":"1544-3191","type":"print"}],"subject":[],"published":{"date-parts":[[2021,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Support and perceived barriers to implementing pre-exposure prophylaxis screening and dispensing in pharmacies: Examining concordance between pharmacy technicians and pharmacists","name":"articletitle","label":"Article Title"},{"value":"Journal of the American Pharmacists Association","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.japh.2020.10.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Published by Elsevier Inc. on behalf of the American Pharmacists Association.","name":"copyright","label":"Copyright"}]}}